Illumina, Inc. vs Pinterest Inc — how do they compare? Illumina, Inc. trades at $189.72 (market cap $29.12B), while Pinterest Inc trades at $22.95 (market cap $13.45B). The key difference: Illumina, Inc. is far larger — about 2.2× Pinterest Inc's market cap, and Illumina, Inc. is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals.
| ILMN | PINS | |
|---|---|---|
Market Cap | $29.12B | $13.45B |
Sector | Health | Media |
52-Week High | $205.10 | $37.95 |
52-Week Low | $91.00 | $15.42 |
Enterprise Value | $30.48B | $13.37B |
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $191.79, up 2.04% today, with a neutral technical signal and strong fundamental recovery. The stock shows bullish moving averages but faces resistance near $194. Recent earnings beats and a return to profitability in 2025, with $850M net income, highlight operational turnaround. Revenue remains stable around $4.3B, supported by robust gross margins of 66.38%.
Outlook is positive with analyst consensus Buy rating and $201.58 price target, though high P/E of 35.98 poses valuation risk. Key opportunities include sequencing demand and AI partnerships, while risks involve debt levels and competitive pressures. Institutional activity is mixed, with some funds increasing stakes amid earnings momentum.
Pinterest (PINS) trades at $24.37, up 2.91% with strong technical momentum as moving averages signal bullish sentiment. The company demonstrates solid fundamental performance with Q2 2026 EPS beating estimates at $0.43 versus $0.36 expected, marking the third consecutive quarterly beat. Revenue growth remains robust at 18% year-over-year, reaching $1.18 billion in Q2 2026, while maintaining a healthy gross profit margin of 79.47%.
The investment outlook appears favorable with 54% analyst buy ratings and a $28.69 consensus price target representing 18% upside potential. However, risks include intense advertising competition from Meta and slowing revenue guidance for Q3 2026. The stock offers value at current levels given strong AI-driven ad growth and record user metrics, though investors should monitor competitive pressures and execution on international expansion.
Trailing returns across standard periods
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →